Pharmaprojects R&D Pipeline News Feed
GlaxoSmithKline makes cancer cell genomic data available to all cancer researchers
24 Jun 2008
GlaxoSmithKline (GSK) has released genomic profiling data for over 300 cancer cell lines via the US National Cancer Institute's cancer Bioinformatics Grid initiative, a network of infrastructure and tools that enables the collection, analysis, and sharing of data and knowledge along the entire research pathway from laboratory bench to patient bedside.
Dr. Richard Wooster, Director of Translational Medicine Oncology, R&D, GSK, said, "We hope this data will further drive the identification of predictive biomarkers and lead to shorter, more directed clinical trials allowing us to bring drugs more quickly to patients who need them".
The data comes from cell lines derived from a wide variety of tumours, including breast, prostate, lung and ovarian cancers. It is hoped that this will reduce the cost and time usually involved in identifying and cataloguing individual cell lines, particularly for smaller or non-commercial organizations.
Interested researchers can download this free data through caArray at https://cabig.nci.nih.gov/tools/caArray.
